Trial
NCT01979276
Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
Celgene Corporation
Condition
Multiple Myeloma
Intervention
Romidepsin
Why stopped
this study was terminated due to losing financial support, and enrollment challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-06